Sherwin-Williams Q4 sales rise 5.6%; 2026 adjusted EPS guided to $11.50-$11.90
Sherwin-Williams reported fourth-quarter 2025 net sales of $5.60 billion, up 5.6%, and diluted earnings of $1.92 per share, up 1.1%. For full-year 2025, diluted EPS fell 2.7% to $10.26 while adjusted diluted EPS rose 0.9% to $11.43, and the company guided 2026 adjusted diluted EPS to $11.50 to $11.90, which it said is a 2.4% increase at the midpoint.
Key points
- Q4 2025 net sales were $5,595.9 million, up 5.6%; adjusted diluted EPS rose 6.7% to $2.23.
- Full-year 2025 net sales were $23.57 billion, up 2.1%, while diluted EPS fell 2.7% to $10.26.
- 2026 guidance: diluted EPS of $10.70 to $11.10 and adjusted diluted EPS of $11.50 to $11.90, excluding $0.80 per share of Valspar acquisition-related amortization.
- Net operating cash for 2025 was $3.45 billion; the company returned $2.45 billion to shareholders through dividends and repurchases.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 29, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.